Cardiology News and Research

Latest Cardiology News and Research

Prominent scientist in mitochondrial genetics joins Children's Hospital to establish CMEM

Douglas C. Wallace, Ph.D., a pioneer and internationally prominent scientist in the field of human mitochondrial genetics, has joined The Children's Hospital of Philadelphia to continue his investigations into the role of mitochondrial energy in health and disease.

29 Oct 2010

Olive oil protects against oxidative damage of hepatic tissue

Extra-virgin olive oil can protect the liver from oxidative stress. Researchers writing in BioMed Central's open access journal Nutrition and Metabolism exposed rats to a moderately toxic herbicide known to deplete antioxidants and cause oxidative stress, finding that those rats fed on a diet containing the olive oil were partially protected from the resulting liver damage.

29 Oct 2010

VIVUS receives FDA CRL for QNEXA NDA

VIVUS, Inc. announced today that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for the investigational new drug QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form.

29 Oct 2010

Stryker enters agreement to acquire assets of Neurovascular division of Boston Scientific

Stryker Corporation announced today a definitive agreement to acquire the assets of the Neurovascular division of Boston Scientific in an all cash transaction for $1.5 billion, which includes $100 million of milestone payments.

From Stryker 29 Oct 2010

ResMed third quarter revenue increases 17% to $282.0 million

ResMed Inc. today announced record revenue and income for the quarter ended September 30, 2010. Revenue for the quarter ended September 30, 2010 was $282.0 million, a 14% increase (a 17% increase on a constant currency basis) over the quarter ended September 30, 2009.

From ResMed Corp 29 Oct 2010

Geron 2010 third quarter revenue increases from $494,000 to $546,000

Geron Corporation today reported financial results for the three and nine months ended September 30, 2010.

29 Oct 2010

Neurocrine third quarter revenue increases from $0.7 million to $14.4 million

Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended September 30, 2010.

29 Oct 2010

Chillies for diabetes: Study

Researchers from Tasmania, Australia are recruiting volunteers in a study to explore if eating chillies can help control lifestyle-related diabetes. At present they need 35 people with type 2 diabetes or glucose intolerance.

28 Oct 2010

CCS presents new 2010 Atrial Fibrillation Guidelines

The Canadian Cardiovascular Society (CCS) presented its new 2010 Atrial Fibrillation Guidelines, the first update in six years, at the Canadian Cardiovascular Congress (CCC) in Montreal.

28 Oct 2010

IsoRay completes Cs-131 brachytherapy seeds feasibility study for breast cancer treatment

IsoRay, Inc. announced, today, it has completed an initial feasibility study, which demonstrates the ability to use its patented Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) in accelerated partial breast irradiation (APBI) for breast cancer treatment.

28 Oct 2010

Teck donates $2.5M to support emergency programs and services at St. Paul's Hospital

St. Paul's Hospital Foundation today announced that Teck Resources Limited donated $2.5 million to St. Paul's Hospital to complete the remaining funding for its recently renovated and redesigned emergency area. In recognition of Teck's major gift, the area will be named the Teck Emergency Centre. Furthermore, a fund to support research, academic productivity and the development of best practices at the hospital will be called the Teck Emergency Centre Innovation Fund.

28 Oct 2010

Scientists suggest FDA to reevaluate safety of plant-based antioxidants

Scientists are calling for more research on the possibility that some supposedly healthful plant-based antioxidants including those renowned for their apparent ability to prevent cancer may actually aggravate or even cause cancer in some individuals.

28 Oct 2010

Mirada Medical and Moffitt Cancer Center enter joint development agreement

Mirada Medical Limited, the fast growing international company focused on advanced oncology imaging, announced today that they have signed an agreement with Moffitt Cancer Center, Tampa, FL, one of the USA's top centers for cancer treatment and oncology research.

28 Oct 2010

Systemic amyloidosis patient to receive triple organ transplant

In 2005, then 40-year-old Walt McGuire was playing hockey twice a week, working full-time and chasing his young daughter. Then one day, he noticed after one trip up the stairs to catch her, he couldn't catch his breath. A few days later his legs were swollen. After numerous trips to different doctors, McGuire finally was diagnosed with a rare blood disorder called amyloidosis.

28 Oct 2010

Abbott provides $180,000 to support recent cholera outbreak in central Haiti

Abbott is providing $180,000 in support to help address the recent cholera outbreak in central Haiti. This includes a $25,000 grant from the Abbott Fund to Partners In Health, and $155,000 in donated Abbott rehydration solutions and antibiotics.

28 Oct 2010

The Methodist Hospital Research Institute opens 12-story, 440,000 square foot research facility

The Methodist Hospital Research Institute® (TMHRI) today opened a 12-story, 440,000 square foot research facility dedicated solely to research and equipped with the world's most advanced technology to help research scientists, physicians and engineers cure diseases that afflict today's patients.

28 Oct 2010

1000 Genomes Project publishes comprehensive map of genetic variations in Nature journal

Small genetic differences between individuals help explain why some people have a higher risk than others for developing illnesses such as diabetes or cancer. Today in the journal Nature, the 1000 Genomes Project, an international public-private consortium, published the most comprehensive map of these genetic differences, called variations, estimated to contain approximately 95 percent of the genetic variation of any person on Earth.

28 Oct 2010

Calypso Medical initiates clinical study to evaluate tracking technology for lung tumors

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumors, today announced the initiation of the first clinical study to evaluate the use of the Calypso System for tracking lung cancer tumors during radiation delivery, including a new design of the Company's implantable Beacon transponder.

28 Oct 2010

New national campaign to drive awareness on DVT and PE prevention in women

As many as 600,000 people are affected by deep vein thrombosis (DVT) and pulmonary embolism (PE) every year, and more than half of those are never diagnosed. Some people experience swelling and varying levels of discomfort in the affected area, and some don't feel anything at all. But the symptoms of DVT can be similar to other conditions, like a pulled muscle, and because some people with DVT do not have any symptoms, there is often a delay in diagnosis. That's when DVT can be fatal.

28 Oct 2010

Health Canada approves PRADAX anticoagulant for stroke prevention in AF patients

Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.

28 Oct 2010

Cardiology News and Research

Latest Cardiology News and Research

Prominent scientist in mitochondrial genetics joins Children's Hospital to establish CMEM

Olive oil protects against oxidative damage of hepatic tissue

VIVUS receives FDA CRL for QNEXA NDA

Stryker enters agreement to acquire assets of Neurovascular division of Boston Scientific

ResMed third quarter revenue increases 17% to $282.0 million

Geron 2010 third quarter revenue increases from $494,000 to $546,000

Neurocrine third quarter revenue increases from $0.7 million to $14.4 million

Chillies for diabetes: Study

CCS presents new 2010 Atrial Fibrillation Guidelines

IsoRay completes Cs-131 brachytherapy seeds feasibility study for breast cancer treatment

Teck donates $2.5M to support emergency programs and services at St. Paul's Hospital

Scientists suggest FDA to reevaluate safety of plant-based antioxidants

Mirada Medical and Moffitt Cancer Center enter joint development agreement

Systemic amyloidosis patient to receive triple organ transplant

Abbott provides $180,000 to support recent cholera outbreak in central Haiti

The Methodist Hospital Research Institute opens 12-story, 440,000 square foot research facility

1000 Genomes Project publishes comprehensive map of genetic variations in Nature journal

Calypso Medical initiates clinical study to evaluate tracking technology for lung tumors

New national campaign to drive awareness on DVT and PE prevention in women

Health Canada approves PRADAX anticoagulant for stroke prevention in AF patients

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cardiology News and Research

Latest Cardiology News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in